VPD’s strategy is to create, invest in, and manage a portfolio of “project-focused companies,” each of which contains a single drug candidate acquired from a third party.

Pharmaceutical

Velocity Pharmaceutical Development

Velocity Pharmaceutical Development's headquarters in South San Francisco, CA, United States

David Collier

Edward Schnipper

Andrew Perlman

Anie Roche

James Larrick

Sonia Kamal

Samuel R. Saks

Karen D. Talmadge

Wayne Roe

James F. Watson

The Leadership Team at Velocity Pharmaceutical Development is responsible for defining the company’s strategic direction, overseeing the management of project-focused companies, and driving decision-making related to drug candidate acquisitions. Composed of seasoned executives, the team collaborates to ensure effective risk management, operational excellence, and alignment with VPD's mission to innovate and advance pharmaceutical development.

Leadership Team

The Medical and Legal Team at Velocity Pharmaceutical Development is responsible for ensuring the scientific integrity and regulatory compliance of drug candidates within the portfolio. This team collaborates closely to evaluate clinical data, navigate legal frameworks, and manage intellectual property issues, all while ensuring adherence to industry standards and ethical practices. Their combined expertise safeguards the company's investments and supports successful project outcomes.

��

Velocity Pharmaceutical Development

Org chart

Board & advisors

Teams

Leadership Team

Medical and Legal Team

Offices

��������

Velocity Pharmaceutical Development

Org chart

Board & advisors

Teams

Leadership Team

Medical and Legal Team

Offices

Related companies

��